Abstract
Production of heterologous proteins in plant systems has become a valuable biotechnological approach as demonstrated by the recent approval of the first plant-made pharmaceutical for the treatment of the rare genetic disorder known as Gaucher’s disease in carrot cell cultures. The main advantages of plants compared to classical expression systems such as bacteria, yeasts or animal cell cultures are the intrinsic safety (e.g. absence of human pathogens), cost-effectiveness and the possibility to manipulate protein post-translational modifications such as glycosylation. Among plant-based production systems, hairy root cultures offer further advantages represented by the possibility of using defined cultivation conditions under contained environment which are attractive for an industrial scale production, the maintenance of product homogeneity and the ease of purification and recovery of the biopharmaceutical product secreted in the culture medium. Several biopharmaceutical products have been successfully produced in hairy root cultures such as vaccine components, enzymes and monoclonal antibodies. In this context, we recently described the production of a tumour-targeting monoclonal antibody with a human-compatible glycosylation pattern in glyco-engineered hairy root cultures. In this chapter we will describe the recent advances in the generation of hairy root cultures expressing heterologous proteins and the strategies adopted to produce biopharmaceuticals, with particular focus on antibodies, and to increase their stability and secretion into the culture medium. Overall, hairy root cultures represent an innovative and promising biotechnological system for the production of plant-made biopharmaceuticals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Altmann F (2007) The role of protein glycosylation in allergy. Int Arch Allergy Immunol 142:99–115. https://doi.org/10.1159/000096114
Bardor M, Faveeuw C, Fitchette A-C et al (2003) Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose. Glycobiology 13:427–434. https://doi.org/10.1093/glycob/cwg024
Doran PM (2000) Foreign protein production in plant tissue cultures. Curr Opin Biotechnol 11:199–204. https://doi.org/10.1016/S0958-1669(00)00086-0
Doran PM (2013) Therapeutically important proteins from in vitro plant tissue culture systems. Curr Med Chem 20:1047–1055
Drake PMW, Barbi T, Sexton A et al (2009) Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco. FASEB J 23:3581–3589. https://doi.org/10.1096/fj.09-131771
Gallie DR, Kado CI (1989) A translational enhancer derived from tobacco mosaic virus is functionally equivalent to a Shine-Dalgarno sequence. Proc Natl Acad Sci U S A 86:129–132
Gaume A, Komarnytsky S, Borisjuk N, Raskin I (2003) Rhizosecretion of recombinant proteins from plant hairy roots. Plant Cell Rep 21:1188–1193. https://doi.org/10.1007/s00299-003-0660-3
Georgiev MI, Agostini E, Ludwig-Müller J, Xu J (2012) Genetically transformed roots: from plant disease to biotechnological resource. Trends Biotechnol 30:528–537. https://doi.org/10.1016/j.tibtech.2012.07.001
Geyer CR, McCafferty J, Dübel S, et al (2012) Recombinant antibodies and in vitro selection technologies. In: Methods in molecular biology, Clifton. pp 11–32
Gomord V, Chamberlain P, Jefferis R, Faye L (2005) Biopharmaceutical production in plants: problems, solutions and opportunities. Trends Biotechnol 23:559–565. https://doi.org/10.1016/j.tibtech.2005.09.003
Gomord V, Fitchette A-C, Menu-Bouaouiche L et al (2010) Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J 8:564–587. https://doi.org/10.1111/j.1467-7652.2009.00497.x
Grabowski GA, Golembo M, Shaaltiel Y (2014) Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. Mol Genet Metab 112:1–8. https://doi.org/10.1016/j.ymgme.2014.02.011
Häkkinen ST, Raven N, Henquet M et al (2014) Molecular farming in tobacco hairy roots by triggering the secretion of a pharmaceutical antibody. Biotechnol Bioeng 111:336–346. https://doi.org/10.1002/bit.25113
Hu Z-B, Du M (2006) Hairy root and its application in plant genetic engineering. J Integr Plant Biol 48:121–127. https://doi.org/10.1111/j.1744-7909.2006.00121.x
Huang Y, Su C-Y, Kuo H-J et al (2013) A comparison of strategies for multiple-gene co-transformation via hairy root induction. Appl Microbiol Biotechnol 97:8637–8647. https://doi.org/10.1007/s00253-013-5034-3
Jefferis R (2009) Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 8:226–234. https://doi.org/10.1038/nrd2804
Kim S-I, Veena GSB (2007) Genome-wide analysis of Agrobacterium T-DNA integration sites in the Arabidopsis genome generated under non-selective conditions. Plant J 51:779–791. https://doi.org/10.1111/j.1365-313X.2007.03183.x
Kim S-R, Sim J-S, Ajjappala H et al (2012) Expression and large-scale production of the biochemically active human tissue-plasminogen activator in hairy roots of Oriental melon (Cucumis melo). J Biosci Bioeng 113:106–111. https://doi.org/10.1016/j.jbiosc.2011.09.008
Lerouge P, Bardor M, Pagny S et al (2000) N-glycosylation of recombinant pharmaceutical glycoproteins produced in transgenic plants: towards an humanisation of plant N-glycans. Curr Pharm Biotechnol 1:347–354
Liu C, Towler MJ, Medrano G et al (2009) Production of mouse interleukin-12 is greater in tobacco hairy roots grown in a mist reactor than in an airlift reactor. Biotechnol Bioeng 102:1074–1086. https://doi.org/10.1002/bit.22154
Lombardi R, Donini M, Villani ME et al (2012) Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation. Transgenic Res 21:1005–1021. https://doi.org/10.1007/s11248-012-9587-1
Loos A, Van Droogenbroeck B, Hillmer S et al (2011a) Production of monoclonal antibodies with a controlled Nglycosylation pattern in seeds of Arabidopsis thaliana. Plant Biotechnol J 9:179–192. https://doi.org/10.1111/j.1467-7652.2010.00540.x
Loos A, Van Droogenbroeck B, Hillmer S, Grass J, Pabst M, Castilho A, Kunert R, Liang M, Arcalis E, Robinson DG, Depicker A, Steinkellner H (2011b) Expression of antibody fragments with a controlled n-glycosylation pattern and induction of endoplasmic reticulum-derived vesicles in seeds of arabidopsis. Plant Physiol 155(4):2036–2048
Lonoce C, Salem R, Marusic C et al (2016) Production of a tumour-targeting antibody with a human-compatible glycosylation profile in N. benthamiana hairy root cultures. Biotechnol J 11:1209–1220. https://doi.org/10.1002/biot.201500628
Ma JK-C, Drossard J, Lewis D et al (2015) Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnol J 13:1106–1120. https://doi.org/10.1111/pbi.12416
Madeira LM, Szeto TH, Henquet M et al (2016) High-yield production of a human monoclonal IgG by rhizosecretion in hydroponic tobacco cultures. Plant Biotechnol J 14:615–624. https://doi.org/10.1111/pbi.12407
MartÃnez C, Petruccelli S, Giulietti AM, Alvarez MA (2005) Expression of the antibody 14D9 in Nicotiana tabacum hairy roots. Electron J Biotechnol 8:170–176
Massa S, Franconi R, Brandi R et al (2007) Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine 25:3018. https://doi.org/10.1016/j.vaccine.2007.01.018
Mehrotra S, Srivastava V, Rahman LU, Kukreja AK (2015) Hairy root biotechnology – indicative timeline to understand missing links and future outlook. Protoplasma 252:1189–1201
Musiychuk K, Stephenson N, Bi H et al (2007) A launch vector for the production of vaccine antigens in plants. Influenza Other Respir Viruses 1:19–25. https://doi.org/10.1111/j.1750-2659.2006.00005.x
Odell JT, Nagy F, Chua N-H (1985) Identification of DNA sequences required for activity of the cauliflower mosaic virus 35S promoter. Nature 313:810. https://doi.org/10.1038/313810a0
Ono NN, Tian L (2011) The multiplicity of hairy root cultures: prolific possibilities. Plant Sci 180:439–446. https://doi.org/10.1016/j.plantsci.2010.11.012
Platis D, Drossard J, Fischer R et al (2008) New downstream processing strategy for the purification of monoclonal antibodies from transgenic tobacco plants. J Chromatogr A 1211:80–89. https://doi.org/10.1016/j.chroma.2008.09.103
Sabalza M, Christou P, Capell T (2014) Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks. Biotechnol Lett 36:2367–2379. https://doi.org/10.1007/s10529-014-1621-3
Sainsbury F, Sack M, Stadlmann J et al (2010) Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody. PLoS One 5:e13976. https://doi.org/10.1371/journal.pone.0013976
Shadwick FS, Doran PM (2007a) Infection, propagation, distribution and stability of plant virus in hairy root cultures. J Biotechnol 131:318–329. https://doi.org/10.1016/j.jbiotec.2007.07.722
Shadwick FS, Doran PM (2007b) Propagation of plant viruses in hairy root cultures: a potential method for in vitro production of epitope vaccines and foreign proteins. Biotechnol Bioeng 96:570–583. https://doi.org/10.1002/bit.21126
Sharp JM, Doran PM (2001a) Characterization of monoclonal antibody fragments produced by plant cells. Biotechnol Bioeng 73:338–346
Sharp JM, Doran PM (2001b) Strategies for enhancing monoclonal antibody accumulation in plant cell and organ cultures. Biotechnol Prog 17:979–992. https://doi.org/10.1021/bp010104t
Skarjinskaia M, Karl J, Araujo A et al (2008) Production of recombinant proteins in clonal root cultures using episomal expression vectors. Biotechnol Bioeng 100:814–819. https://doi.org/10.1002/bit.21802
Skarjinskaia M, Ruby K, Araujo A et al (2013) Hairy roots as a vaccine production and delivery system. Adv Biochem Eng Biotechnol 134:115–134. https://doi.org/10.1007/10_2013_184
Srivastava V, Mehrotra S, Verma PK (2016) Biotechnological interventions for production of therapeutic secondary metabolites using hairy root cultures of medicinal plants. In: Current developments in biotechnology and bioengineering: crop modification, nutrition, and food production, Elsevier Inc., pp 259–282
Strasser R, Stadlmann J, Schähs M et al (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 6:392–402. https://doi.org/10.1111/j.1467-7652.2008.00330.x
Strasser R, Altmann F, Steinkellner H (2014) Controlled glycosylation of plant-produced recombinant proteins. Curr Opin Biotechnol 30:95–100. https://doi.org/10.1016/j.copbio.2014.06.008
van Ree R, Cabanes-Macheteau M, Akkerdaas J et al (2000) Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J Biol Chem 275:11451–11458
Vézina L-P, Faye L, Lerouge P et al (2009) Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol J 7:442–455. https://doi.org/10.1111/j.1467-7652.2009.00414.x
White FF, Taylor BH, Huffman GA et al (1985) Molecular and genetic analysis of the transferred DNA regions of the root-inducing plasmid of Agrobacterium rhizogenes. J Bacteriol 164:33–44
Wongsamuth R, Doran PM (1997) Production of monoclonal antibodies by tobacco hairy roots. Biotechnol Bioeng 54:401–415. https://doi.org/10.1002/(SICI)1097-0290(19970605)54:5<401::AID-BIT1>3.0.CO;2-I
Yusibov V, Kushnir N, Streatfield SJ (2016) Antibody production in plants and green algae. Annu Rev Plant Biol 67:669–701. https://doi.org/10.1146/annurev-arplant-043015-111812
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Donini, M., Marusic, C. (2018). Hairy Roots as Bioreactors for the Production of Biopharmaceuticals. In: Srivastava, V., Mehrotra, S., Mishra, S. (eds) Hairy Roots. Springer, Singapore. https://doi.org/10.1007/978-981-13-2562-5_9
Download citation
DOI: https://doi.org/10.1007/978-981-13-2562-5_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2561-8
Online ISBN: 978-981-13-2562-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)